59 / 100

Dr. Regine SITRUK WARE | Endocrinology | Best Researcher Award

Dr.Regine SITRUK WARE, Population Council, United States

Dr. Regine Sitruk-Ware is a prominent researcher affiliated with the Population Council in the United States. She has made significant contributions to the fields of reproductive health and contraception, particularly in the development of innovative contraceptive technologies. Her work focuses on advancing women’s health through the introduction of safe and effective contraceptive methods. Sitruk-Ware’s research has been instrumental in shaping global reproductive health policies and practices, addressing critical issues such as family planning and women’s empowerment worldwide.




Paris University, Medical School, France,M.D., 1975, Medicine (Silver Medal),Specialist, 1976, Internal Medicine,Specialist, 1981, Reproductive Endocrinology 


Dr. RĂ©GINE SITRUK-WARE currently serves as a Distinguished Scientist at the Population Council in New York, NY, where she has been pivotal in advancing reproductive health research and development. Her career spans roles in academia, industry, and international organizations, focusing on reproductive endocrinology and drug development.

Industry and International Roles 

Head of International Medical Affairs, Ciba-Geigy, Basle, Switzerland (1989-1995),Head of Research and Development, Theramex, Monaco (1995-1997),Head of Medicine, Research & Development, Exelgyn, Paris, France (1997-2000),Executive Director Research & Development, Population Council, New York, NY (2000-2010),Distinguished Scientist, Population Council, New York, NY (2010-present)


Dr. Sitrak-Ware’s expertise spans preclinical and clinical research, drug safety, and the development of reproductive health technologies. She has a strong background in leading multidisciplinary teams and managing international collaborations in the pharmaceutical and academic sectors.

Research Focus

Dr. Sitrak-Ware’s research focuses on:,Development of novel contraceptive technologies, including non-surgical permanent contraception.,Pharmacology and therapeutic potential of progestins, particularly in neuroprotection and myelin repair.,Non-oral delivery systems for hormonal therapies and contraceptives.


Dr. Sitrak-Ware has published extensively in peer-reviewed journals, contributing significant findings to the fields of reproductive endocrinology, contraceptive technologies, and pharmacology. Selected publications include:

  • Chen S, Kumar N, Mao Z, Sitruk-Ware R, Brinton RD. Therapeutic progestin segesterone acetate promotes neurogenesis: implications for sustaining regeneration in female brain. Menopause. 2018;25(10):1138-1151.
  • El-Etr M, Rame M, Boucher C, et al. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions. Glia. 2015;63(1):104-117.
  • Gemzell-Danielsson K, Sitruk-Ware R, Creinin MD, et al. Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation. Contraception. 2019;99(6):323-328.
  • Brache V, Vieira CS, Plagianos M, et al. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study. Contraception. 2021;104(4):327-336.
Regine SITRUK WARE | Endocrinology | Best Researcher Award

You May Also Like